Item
Nose Spray Vaccines Could Quash COVID Virus Variants
Title (Dublin Core)
Nose Spray Vaccines Could Quash COVID Virus Variants
Description (Dublin Core)
This is a news story from The Scientific American by Marla Broadfoot. With the effectiveness of vaccines waning due to new variants coming about, scientists have been coming up with new ways to combat the virus. Scientists are thinking of developing a nose spray vaccine that attacks the virus at the source. It is believed that a vaccine delivered this method could trigger mucosal immunity. Nasal vaccines have been shown in the past to be more effective than traditional administration of vaccines. There is risk in this, however, because there still needs to be more research done on mucosal immunity. The advantage is that this vaccine does not rely on syringes or needles, so it has the possibility of reaching more people.
Date (Dublin Core)
May 3, 2022
Creator (Dublin Core)
Marla Broadfoot
Event Identifier (Dublin Core)
HST580
Partner (Dublin Core)
Arizona State University
Type (Dublin Core)
Text story
Link (Bibliographic Ontology)
Controlled Vocabulary (Dublin Core)
English
Health & Wellness
English
Healthcare
Curator's Tags (Omeka Classic)
nasal vaccine
nose
mucus
Meissa Vaccines
Codagenix
clinical trial
Contributor's Tags (a true folksonomy) (Friend of a Friend)
vaccine
science
nasal spray
mucosal immunity
research
HST580
ASU
Linked Data (Dublin Core)
Date Submitted (Dublin Core)
05/06/2022
Date Modified (Dublin Core)
05/16/2022
07/09/2022
08/02/2022
Date Created (Dublin Core)
05/03/2022
Item sets
This item was submitted on May 6, 2022 by [anonymous user] using the form “Share Your Story” on the site “A Journal of the Plague Year”: https://covid-19archive.org/s/archive
Click here to view the collected data.